Eshan Khan
Overview
Explore the profile of Eshan Khan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
230
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan E, Hylton H, Rajan N, Bouley S, Siddiqui J, Rajasekaran S, et al.
Thyroid
. 2025 Jan;
35(2):177-187.
PMID: 39868924
Medullary thyroid cancer (MTC) is a frequently metastatic tumor of the thyroid that develops from the malignant transformation of C-cells. These tumors most commonly have activating mutations within the RET...
2.
Chauhan N, Anand A, Sharma A, Dhiman K, Gosain T, Singh P, et al.
Microbiol Spectr
. 2022 Dec;
11(1):e0197322.
PMID: 36507689
In order to adapt in host tissues, microbial pathogens regulate their gene expression through a variety of transcription factors. Here, we have functionally characterized Rv0792c, a HutC homolog from Mycobacterium...
3.
Dar M, Kumar P, Kumar P, Shrivastava A, Dar M, Chauhan R, et al.
Vaccines (Basel)
. 2022 Nov;
10(11).
PMID: 36366359
Gallbladder cancer (GBC) is an aggressive and difficult to treat biliary tract carcinoma with a poor survival rate. The aim of this study was to design a peptide-based multi-epitope vaccine...
4.
Rajasekaran S, Khan E, Ching S, Khan M, Siddiqui J, Gradia D, et al.
Nucleic Acids Res
. 2022 Jun;
50(12):7048-7066.
PMID: 35736218
DICER1 syndrome is a cancer pre-disposition disorder caused by mutations that disrupt the function of DICER1 in miRNA processing. Studying the molecular, cellular and oncogenic effects of these mutations can...
5.
Verma A, Khan E, Mishra S, Kumar A
Mol Neurobiol
. 2022 Jan;
59(3):1992-2007.
PMID: 35040038
Expansion of CGG trinucleotide repeats in 5' untranslated region of the FMR1 gene is the causative mutation of neurological diseases such as fragile X syndrome (FXS), fragile X-associated tremor/ataxia syndrome...
6.
Rajasekaran S, Siddiqui J, Rakijas J, Nicolay B, Lin C, Khan E, et al.
Commun Biol
. 2021 Oct;
4(1):1156.
PMID: 34593978
No abstract available.
7.
Rajasekaran S, Siddiqui J, Rakijas J, Nicolay B, Lin C, Khan E, et al.
Commun Biol
. 2021 Aug;
4(1):977.
PMID: 34404904
Inactivation of RB is one of the hallmarks of cancer, however gaps remain in our understanding of how RB-loss changes human cells. Here we show that pRB-depletion results in cellular...
8.
Anand A, Chatterjee B, Dhiman A, Goel R, Khan E, Malhotra A, et al.
Biosens Bioelectron
. 2021 Aug;
193:113523.
PMID: 34333364
Complex target SELEX always have been an intriguing approach to the scientific community, as it offers the potential discovery of novel biomarkers. We herein successfully performed SELEX on Bungarus caeruleus...
9.
Binzel D, Li X, Burns N, Khan E, Lee W, Chen L, et al.
Chem Rev
. 2021 May;
121(13):7398-7467.
PMID: 34038115
RNA nanotechnology is the bottom-up self-assembly of nanometer-scale architectures, resembling LEGOs, composed mainly of RNA. The ideal building material should be (1) versatile and controllable in shape and stoichiometry, (2)...
10.
Yu L, Wang X, Zhang W, Khan E, Lin C, Guo C
Life Sci
. 2021 Jan;
268:118995.
PMID: 33421524
Metastasis is one of the leading causes of mortality in cancer patients. As the firstly identified metastasis suppressor, NM23-H1 has been endowed with expectation as a potent target in metastatic...